Form 4 for TDOC Teladoc Health, Inc.
Accepted 2024-12-03 00:00:00 ET · period of report 2024-11-29 · accession 0001628280-24-049797 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-12-03 | 2024-12-02 | TDOC | Murthy Mala | CFO | S - Sale+OE | $11.93 | -8,783 | 92.8K | -9% | -$104.8K |
| DM | 2024-12-03 | 2024-11-29 | TDOC | Murthy Mala | CFO | M - OptEx | — | +15.8K | 101.6K | +18% | — |
| DM | 2024-12-03 | 2024-11-29 | TDOC | Murthy Mala | CFO | M - OptEx | $0.00 | -15.8K | 38.8K | -29% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-02 | S | D | 8,783 | $11.93 | 92,788 | D | — | — | (F3) Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. |
| 2 | Common | Common Stock | 2024-11-29 | M | A | 2,641 | — | 88,408 | D | — | — | (F1) Performance stock units convert to shares of TDOC common stock on a one-for-one basis. |
| 3 | Common | Common Stock | 2024-11-29 | M | A | 2,044 | — | 93,821 | D | — | — | (F2) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. |
| 4 | Common | Common Stock | 2024-11-29 | M | A | 3,369 | — | 91,777 | D | — | — | (F2) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. |
| 5 | Common | Common Stock | 2024-11-29 | M | A | 7,750 | — | 101,571 | D | — | — | (F2) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. |
| 6 | Derivative | Performance Stock Units | 2024-11-29 | M | D | 2,641 | $0.00 | 13,208 | D | — · — to — | 2,641 Common Stock | (F1) Performance stock units convert to shares of TDOC common stock on a one-for-one basis. (F4) On March 1, 2024, the reporting person earned 31,696 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| 7 | Derivative | Restricted Stock Units | 2024-11-29 | M | D | 3,369 | $0.00 | 3,369 | D | — · — to — | 3,369 Common Stock | (F2) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. (F5) On March 1, 2022, the reporting person was granted 40,426 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| 8 | Derivative | Restricted Stock Units | 2024-11-29 | M | D | 2,044 | $0.00 | 4,088 | D | — · — to — | 2,044 Common Stock | (F2) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. (F6) On June 1, 2022, the reporting person was granted 24,525 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| 9 | Derivative | Restricted Stock Units | 2024-11-29 | M | D | 7,750 | $0.00 | 38,754 | D | — · — to — | 7,750 Common Stock | (F2) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. (F7) On March 3, 2023, the reporting person was granted 93,006 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. |